asthma copd inhalers Flashcards
MDI counseling points
-need to prime (prime 4x b4 use)
-inhale slowly, deeply
-normally shake (UNLESS if solution then DONT shake)
-if need to shake, shake 10 to 15 times
-can use a spacer
solution MDI so don’t shake: alvesco, atrovent
respimat: soft, mist
DO NOT SHAKE
P-TOP
~prime it
~turn it
~open it
~press it
DPI counseling points
-inhale quickly and deeply (to pull into lungs)
-do NOT shake
-all are contraindicated in milk protein allergy
-store at room temp in a dry place
-do NOT exhale into the container
-single dose devices require placement of a capsule into the device immediately before each treatment (ex: indacaterol - arcapta neohaler, tiotropium - spiriva handihaler, indacaterol + glycopyrrolate - utibron)
asthma medication triggers
NSAIDs (including ASA) and beta blockers
albuterol dosage forms
-MDI
-DPI
-Nebulization
-Syrup
-Tablets (ER, IR)
albuterol: MDI examples
-ventolin HFA
-Proventil HFA
-ProAir HFA
albuterol: DPI examples
-ProAir RespiClick
levalbuterol (forms)
xopenex (R-isomer of albuterol)
xopenex HFA, MDI
xopenex nebulization
terbutaline (forms)
oral
injectable (SQ/IV)
beclomethasone (forms)
breath-actuated aerosol inhaler
QVAR redihaler, MDI
NO SPACER
budesonide (forms)
pulmicort flexhaler (DPI)
pulmicort respules (contains liquid for nebulizer)
mometasone (forms)
asmanex HFA, MDI
asmanex twisthaler DPI
fluticasone (forms)
flovent HFA (MDI)
flovent diskus (DPI)
arnuity ellipta (DPI)
ciclesonide (forms)
alvesco (MDI)
*prodrug requires hydrolyzation in the lung to form the active metabolite
*MDI BUT IS A SOLUTION –> DO NOT SHAKE
flunisolide (forms)
aerospan HFA (D/C’ed)
systemic steroids for acute tx of asthma
(along with a SABA)
-oral prednisone: 40 - 60mg QD x3 - 10 days
-dexamethasone: 16mg/d PO QD x1 - 2 days
-methylprednisolone (medrol dose pack): Taper 24 to 0 mg PO over 6 days. Start with 6, 5 –> 1mg (all tabs are 4 mg, total of 21 tabs)
-rayos (delayed release prednisone): QHS; coated to delay drug about 4 hr after the dose is taken
oral prednisolone formulations
-millipred: 10mg/5 mL, 5 mg tablet
-prelone: 5mg/5 mL, 15 mg/5 mL; contains 5% alcohol
-veripred 20: 20 mg/5 mL solution; REFRIGERATE
-generic: 15mg/5 mL
-orapred: 10, 15, 30 mg ODT
*administer with food or milk to decrease GI upset
*prednisone is a prodrug to prednisolone
salmeterol (forms)
[salmeterol is a CYP3A4 substrate]
-serverent diskus: 1 puff 30 to 60 minutes before exercise
-if includes fluticasone = Advair (Diskus / HFA)
*also approved for maintenance of COPD
-if includes fluticasone = AirDuo RespiClick (DPI)
formoterol (forms)
-formoterol + budesonide (Symbicort)
-formoterol + mometasone (Dulera)
*drug interactions:
-beta blockers may reduce efficacy
-theophylline, caffeine, thiazides, loop diuretics may increase
-beta-agonist-induced decreased K
montelukast (forms)
-singulair: tabs, chewable tabs, granules packet (if mixed, use within 15 minutes)
*indications: asthma, allergic rhinitis (seasonal or perennial), prevention of exercise-induced asthma (must be taken 2 hours before exercise)
10mg QHS: >/= 15 years old
5mg QHS: 6 - 14 years old
4mg QHS: 2 - 5 years old
4mg granules: 6 months - 23 months (QD)
*chewable tab has phenylalanine
*watch for mood and behavioral changes
*restlessness is a side effect
zafirlukast (forms)
-accolate: tabs
*indication: prophylaxis/chronic treatment of asthma
Dose:
-if >/= 12, 20 mg BID on an empty stomach (1 h ac or 2 h pc)
-if 5 - 11, 10 mg BID on an empty stomach
Drug interactions:
-major CYP2C9 substrate / inhibits 2C9
-theophylline may decrease accolate levels
-accolate increases warfarin levels: monitor INR
Caution:
-hepatotoxicity
zileuton (forms)
zyflo, zyflo CR (IR, ER tabs)
Indication: asthma for patients >/= 12
omalizumab
Xolair: subQ (IgG1k mAb)
Indications:
-allergic asthma: >/= 6 years
-chronic idiopathic urticaria (hives): >/= 12 years
*not used for the tx of acute asthma
reslizumab
meplizumab
benralizumab
(forms)
interleukin-5 receptor antagonists
reslizumab (cinqair): IV in NS (IV q4 weeks)
meplizumab (nucala): subQ (subQ q4 weeks)
benralizumab (fasenra): subQ (subQ q4 weeks), then q8 weeks thereafter
theophylline (forms)
elixophyllin: elixir
theo-24: ER caps, QHS
theochron ER-12H: ER tabs
-MOA: phosphodiesterase inhibitors
-MAX = 900mg/d
-DI: strong cyp1a2 substrate & minor 3a4 substrate
-also in IV
Therapeutic levels:
-Children: 5 - 10 mcg/ml
-Adults: 5 - 15 mcg/ml
theophylline - Aminophylline conversion
PO T = IV A x 0.8
methylxanthines used in apnea of prematurity
-caffeine CITRATE: IV
-theophylline
cromolyn (forms)
mast-cell stabilizer
Indications:
-asthma, maintenance
-prophylaxis of bronchospasm (allergen or exercise-induced)
Dosage form: nebulized solution 20mg/2 mL
ipratropium (forms)
atrovent HFA (MDI) = solution (DO NOT SHAKE)
2-3 puffs QID
SE: dry mouth, cough, blurred vision
albuterol + ipratropium (forms)
combivent respimat = DO NOT SHAKE
QID
NOT contraindicated with soybean or peanut allergy
Discard after 3 months after the cartridge is inserted
albuterol + ipratropium solution
DuoNeb: Nebulizer solution
QID PRN
tiotropium (forms)
advantage = QD
spiriva handihaler DPI
spiriva respimat SMI (soft mist inhaler)
*2 inhalations
umeclidinium (forms)
incruse ellipta, dry powder
dose = QD
aclidinium (forms)
tudorza pressair DPI
dose = BID
discard 45 days after opening
glycopyrrolate (forms)
seebri DPI w/ capsule
*dose = 1 c BID
lonhala magnair nebulization solution
*dose = one vial inhaled BID
olodaterol + tiotropium
stiolto respimat
2 QD
indacaterol + glycopyrrolate
utibron neohaler
BID
vilanterol + umeclidinium
anora ellipta
1 QD
formoterol + glycopyrrolate (forms)
bevespi aerosphere MDI
2 BID
formoterol + aclidinium
duaklir pressair
1 BID
formoterol + budesonide (forms)
symbicort MDI
2 BID
salmeterol + fluticasone
advair diskus
1 BID
vilanterol + fluticasone (forms)
breo ellipta DPI (ONLY FOR COPD)
1 QD
contraindicated in milk protein allergy
trelegy ellipta
umeclidinium + vilanterol + fluticasone
FDA approved for both asthma and COPD
Dose = Single puff QD
Contraindication = hypersensitivity to milk proteins
roflumilast
daliresp
indication = COPD maintenance
moa = phosphodiesterase 4 (PDE4) inhibitor
not indicated for acute attack
form = 250, 500 mcg tablet
SE = psych, suicidality, weight LOSS, decreased appetite
DI = major cyp3a4 substrate
CI = moderate-severe liver impairment
THIS IS LAST LINE THERAPY
most effective tx for nasal symptoms is a
CORTICOSTEROID NASAL SPRAY
beclomethasone (forms): AR
beconase (in asthma = QVAR)
flunisolide (forms): AR
…not listed
mometasone (forms): AR
nasonex
OTC
ciclesonide (forms): AR
omnaris
zetonna
triamcinolone (forms): AR
nasacort allergy 24 hr
OTC
budesonide (forms): AR
rhinocort
OTC
fluticasone furoate (forms): AR
flonase sensimist
OTC
antihistamines
azelastine (forms): AR
astepro
antihistamines
olopatadine (forms): AR
patanase
antihistamine/steroid
azelastine/fluticasone (forms): AR
dymista
antihistamine/steroid
olopatadine/mometasone (forms): AR
ryaltris
mast cell stabilizer
cromolyn (forms): AR
nasalcrom
OTC
anticholinergic
ipratropium: AR
…none listed
dupilumab
dupixent
MOA: interleukin-4 receptor antagonist
Indication: add on for moderate-to-severe asthma, atopic dermatitis
Dose: >/= 12 yrs; 200 or 300 mg SQ once every other week
Counseling:
*allow solution to reach room temperature
*DO NOT SHAKE
*DONT USE IF DISCOLORED OR CONTAINS PARTICULATE MATTER
*PREFILLED SYRINGE DOES NOT CONTAIN A PRESERVATIVE; discard unused portion
fluticasone + salmeterol
[new generic formulation for advair diskus]
Wixela Inhub
*THIS IS GRAY, NOT PURPLE LIKE THE DISKUS
*PTS HOLD THIS VERTICALLY INSTEAD OF HORIZONTALLY
aclidinium + formoterol (forms)
duaklir pressair DPI
indication: COPD
dose: one inhalation BID
budesonide/glycopyrrolate/formoterol
breztri aerosphere MDI
indication: COPD
dose: oral inhalation; 2 inhalations BID [this is the MAX]
intravenous Mg Sulfate
off-label for severe or life-threatening exacerbations nonresponsive to initial therapy for asthma or COPD
IV: 2 g as a single dose over 20 minutes
NOTE –> IV Mg is also used for:
-eclampsia/preeclampsia w/ severe features, seizure prophylaxis and tx
-hypomagnesemia
-torsades de pointes